CA Research Funding Bill Moves Through State Legislature With UAEM’s Support
For Immediate Release: June 10, 2026
Contact: Cassidy Parshall, cassidy@uaem.org
SACRAMENTO, C.A. — In response to the federal attack on scientific research funding, California Senators Wiener, Pérez, and Wahab introduced SB 895, the California Science and Health Research Bond Act. This legislation, which has passed the California State Senate and is currently moving through the California State Assembly, would put a bond measure on the November 2026 ballot to fund critical research at California institutions that is at risk of being eliminated by the Trump Administration.
Yesterday, Allison Lee, UAEM Access Committee Member, shared UAEM’s support for the bill at the California State Assembly Committee on Health hearing, where it passed. Ahead of the hearing, Allison submitted UAEM’s official letter of support to Health Committee Chair Mia Bonta.
Publicly funded research is foundational for our pharmaceutical innovation system. The California Science and Health Research Bond Act not only aims to fully restore the Californian innovation that Americans rely on, but ensures that the public—the funder of the initiative—is able to benefit from the innovations produced. Through access conditions that stipulate discounted end products and provisions to allow the recoupment of licensing and royalty fees, the initiative is designed for both access and sustainability.
Additionally, the legislation lays the groundwork for CalRx, California’s initiative to publicly manufacture pharmaceuticals, to produce the innovations resulting from the bond-funded research. The legislation also seeks to support early career scientists through this research funding, another important aspect of ensuring the strength of our biomedical research and development system.
Allison Lee shares UAEM’s support for SB 895 in front of the California State Assembly Health Committee.
###